Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

May 14, 2010 — A new pooled analysis of randomized trials of tissue plasminogen activator (tPA) in the treatment of acute ischemic stroke, now expanded to include more recent trials, confirms the ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

New findings from German researchers suggest that giving tPA treatment to patients within 4.5 hours of a stroke--rather than the approved treatment limit of three hours--may still benefit patients.

Patients with ischemic stroke on antiplatelet therapy are at a significantly higher risk for symptomatic intracranial hemorrhage (sICH) following thrombolysis, but the absolute increased risk is small ...

GLENDALE, Calif. (KABC) -- When a person has a stroke getting treatment within hours is crucial. But now, local researchers are studying a new drug that could change the way stroke is treated, giving ...

Charleston, SC - Patients who have acute ischemic stroke on the weekend are more likely to receive aggressive treatment, including thrombolysis, than those patients who have an event during the week, ...